<http://schema.org/url>
<https://www.genengnews.com/>
<http://www.genengnews.com/Login.aspx?ReturnURL=%2Fgen-news-highlights%2Fbayer-plans-2012-filing-for-regorafenib-following-positive-phase-iii-mcrc-trial-results%2F81246221%2F>